Integra

Integra LifeSciences to Reschedule the First Quarter 2024 Financial Results Conference Call to May 6, 2024

Retrieved on: 
Thursday, April 18, 2024
Integra, EDT

PRINCETON, N.J., April 18, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today announced that it has rescheduled the release of the Company’s first quarter 2024 financial results to Monday, May 6, 2024.

Key Points: 
  • PRINCETON, N.J., April 18, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today announced that it has rescheduled the release of the Company’s first quarter 2024 financial results to Monday, May 6, 2024.
  • In conjunction with the earnings release, Integra’s management team will host a conference call at 8:30 a.m. EDT.
  • A live webcast will be available on the Investors section of the Company’s website at investor.integralife.com .
  • A webcast replay of the conference call will be available on the Investors section of the Company’s website following the call.

Qlik Sets the Pace for Real-World AI Business Transformations Across Industries

Retrieved on: 
Tuesday, April 16, 2024
Indian Oil Corporation, Integra, Ecosystem, AI, Health care, Digital marketing, Artificial intelligence, Digital, Patient, Financial services, Data management, CRM, Risk assessment, AI accelerator

PHILADELPHIA, April 16, 2024 (GLOBE NEWSWIRE) -- Qlik®, a global leader in data integration, analytics, and artificial intelligence (AI), has enabled the integration of AI across industries, driving substantial business outcomes. In its latest effort to make AI more approachable for enterprises at all stages of technological adoption, Qlik announces the AI Accelerator. This service is designed as an initial foray for companies looking to explore the possibilities AI can offer, acting as an entry point into the broader landscape of AI-driven analytics.

Key Points: 
  • Empowering Businesses to Embark on AI with Ease, Qlik also Introduces a Rapid-Deployment AI Accelerator
    PHILADELPHIA, April 16, 2024 (GLOBE NEWSWIRE) -- Qlik® , a global leader in data integration, analytics, and artificial intelligence (AI), has enabled the integration of AI across industries, driving substantial business outcomes.
  • In its latest effort to make AI more approachable for enterprises at all stages of technological adoption, Qlik announces the AI Accelerator.
  • The impact of Qlik's AI solutions demonstrates the practical benefits and strategic value of deploying AI on top of solid data foundations.
  • Digital Marketing: RevLocal improved customer retention by 7% through predictive analysis using Qlik AutoML, highlighting the direct correlation between AI application and business growth.

Integra Optics Unveils Groundbreaking XGS-PON & GPON Combo OLT SFP+ Optical Transceiver

Retrieved on: 
Wednesday, April 10, 2024
Integra, MSA, DDM, GPON, QSFP28, ONU, Electronics, PON, Network interface device, SMF, Telecommunications, Data-rate units, Temperature, WDM, Telescopic sight

IRVINE, Calif., April 10, 2024 /PRNewswire-PRWeb/ -- Integra Optics., an Infinite Electronics brand and innovative, global supplier of carrier-grade fiber optic components, has announced the launch of its latest innovation, the XGS-PON & GPON combo OLT SFP+ BiDi optical transceiver module. This module integrates the functionality of XG(S) PON OLT and GPON OLT optical modules, facilitating seamless network rate deployment within Optical Distribution Networks (ODNs) based on Optical Network Unit (ONU) requirements.

Key Points: 
  • IRVINE, Calif., April 10, 2024 /PRNewswire-PRWeb/ -- Integra Optics., an Infinite Electronics brand and innovative, global supplier of carrier-grade fiber optic components, has announced the launch of its latest innovation, the XGS-PON & GPON combo OLT SFP+ BiDi optical transceiver module .
  • This module integrates the functionality of XG(S) PON OLT and GPON OLT optical modules, facilitating seamless network rate deployment within Optical Distribution Networks (ODNs) based on Optical Network Unit (ONU) requirements.
  • This transceiver module enables a smooth transition from GPON to XG/XGS-PON, effectively future-proofing network infrastructures against evolving demands without necessitating infrastructure overhaul.
  • Integra Optics' new XGS-PON & GPON combo OLT SFP+ BiDi optical transceiver module is available and ready for immediate use.

Integra Optics Unveils Groundbreaking XGS-PON & GPON Combo OLT SFP+ Optical Transceiver

Retrieved on: 
Wednesday, April 10, 2024
Integra, MSA, DDM, GPON, QSFP28, ONU, Electronics, PON, Network interface device, SMF, Telecommunications, Data-rate units, Temperature, WDM, Telescopic sight

IRVINE, Calif., April 10, 2024 /PRNewswire/ -- Integra Optics., an Infinite Electronics brand and innovative, global supplier of carrier-grade fiber optic components, has announced the launch of its latest innovation, the XGS-PON & GPON combo OLT SFP+ BiDi optical transceiver module. This module integrates the functionality of XG(S) PON OLT and GPON OLT optical modules, facilitating seamless network rate deployment within Optical Distribution Networks (ODNs) based on Optical Network Unit (ONU) requirements.

Key Points: 
  • IRVINE, Calif., April 10, 2024 /PRNewswire/ -- Integra Optics., an Infinite Electronics brand and innovative, global supplier of carrier-grade fiber optic components, has announced the launch of its latest innovation, the XGS-PON & GPON combo OLT SFP+ BiDi optical transceiver module .
  • This module integrates the functionality of XG(S) PON OLT and GPON OLT optical modules, facilitating seamless network rate deployment within Optical Distribution Networks (ODNs) based on Optical Network Unit (ONU) requirements.
  • This transceiver module enables a smooth transition from GPON to XG/XGS-PON, effectively future-proofing network infrastructures against evolving demands without necessitating infrastructure overhaul.
  • Integra Optics' new XGS-PON & GPON combo OLT SFP+ BiDi optical transceiver module is available and ready for immediate use.

Integra LifeSciences Completes the Acquisition of Acclarent, Inc.

Retrieved on: 
Monday, April 1, 2024
Nose, Ear, Integra, Acquisition, Neurosurgery, ENT

PRINCETON, N.J., April 01, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced it has successfully completed its acquisition of Acclarent, Inc. , a pioneer in ear, nose and throat (ENT) surgical interventions.

Key Points: 
  • PRINCETON, N.J., April 01, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced it has successfully completed its acquisition of Acclarent, Inc. , a pioneer in ear, nose and throat (ENT) surgical interventions.
  • The addition of Acclarent's innovative product portfolio expands the breadth of Integra’s market-leading brands and provides immediate scale and accretive growth via a dedicated sales channel.
  • The acquisition adds $1 billion to the total addressable market of the Company’s offerings, while providing unique market opportunities for access to the attractive ENT device segment.
  • A webcast replay of the conference call will be posted on the investor section of the Company’s website following the call.

Global Elbow Replacement Market to surpass $200.4 million by 2031, at a CAGR of 4.2%, says Coherent Market Insights

Retrieved on: 
Monday, April 8, 2024
Longevity, Rheumatoid arthritis, Prevalence, Partnership, Patient, AAOS, Elbow, Polyethylene, American Academy, Acquisition, Motion, Quality of life, Injury, Integra, Shoulder, Metal, Partial, Key, Pain, Osteoarthritis, USD, Collection, Plumbing

Elbow replacement surgery is a medical procedure that involves replacing a damaged or diseased elbow joint with an artificial implant.

Key Points: 
  • Elbow replacement surgery is a medical procedure that involves replacing a damaged or diseased elbow joint with an artificial implant.
  • As per the market research report, the elbow replacement market was valued at USD 144.2 million in 2023, with a projected CAGR of 4.2% during the forecast period 2024-2031.
  • Buy this Complete Business Research Report: https://www.coherentmarketinsights.com/insight/buy-now/6663
    In terms of type, the elbow replacement market is segmented into partial elbow replacement and total elbow replacement.
  • Partial elbow replacement is expected to dominate the market, owing to its less invasive nature and shorter recovery time compared to total elbow replacement.

Global Elbow Replacement Market to surpass $200.4 million by 2031, at a CAGR of 4.2%, says Coherent Market Insights

Retrieved on: 
Monday, April 8, 2024
Longevity, Rheumatoid arthritis, Prevalence, Partnership, Patient, AAOS, Elbow, Polyethylene, American Academy, Acquisition, Motion, Quality of life, Injury, Integra, Shoulder, Metal, Partial, Key, Pain, Osteoarthritis, USD, Collection, Plumbing

Elbow replacement surgery is a medical procedure that involves replacing a damaged or diseased elbow joint with an artificial implant.

Key Points: 
  • Elbow replacement surgery is a medical procedure that involves replacing a damaged or diseased elbow joint with an artificial implant.
  • As per the market research report, the elbow replacement market was valued at USD 144.2 million in 2023, with a projected CAGR of 4.2% during the forecast period 2024-2031.
  • Buy this Complete Business Research Report: https://www.coherentmarketinsights.com/insight/buy-now/6663
    In terms of type, the elbow replacement market is segmented into partial elbow replacement and total elbow replacement.
  • Partial elbow replacement is expected to dominate the market, owing to its less invasive nature and shorter recovery time compared to total elbow replacement.

Turkish Broker Integra Licenses CyberCube Software to Bolster Cyber Growth

Retrieved on: 
Monday, March 25, 2024
Software, Insurance, Networks, Data Analytics, Data Management, Professional Services, Technology, Security, Risk, Integra, Ecosystem

Integra Insurance and Reinsurance Broking Services is to become the first Turkish broker to roll out CyberCube’s Broking Manager , the cyber risk analytics platform for insurance intermediaries.

Key Points: 
  • Integra Insurance and Reinsurance Broking Services is to become the first Turkish broker to roll out CyberCube’s Broking Manager , the cyber risk analytics platform for insurance intermediaries.
  • Integra holds a prominent position in the Turkish market as the leading cyber insurance broker.
  • It will license Broking Manager to bolster its growth plans for cyber and gain a competitive edge in this market.
  • Emma Drouineau, Sales Manager at CyberCube, said: “Integra will be the first Turkish broker to utilize CyberCube’s Broking Manager platform to better support clients with their cyber insurance needs.

Integra LifeSciences Launches MicroMatrix® Flex to Provide Convenient Access to Hard-to-Reach Areas in Complex Cases

Retrieved on: 
Monday, March 11, 2024
Flex, Regenerative medicine, Integra, Global marketing, Surgeon, UBM, Development, Research, Management

PRINCETON, N.J., March 11, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), today announced MicroMatrix® Flex is now available commercially in the U.S. MicroMatrix Flex is a dual-syringe system enabling the convenient mixing and precise delivery of MicroMatrix® paste to provide convenient access to hard-to-reach spaces and to help prepare an even wound surface in challenging wound areas.

Key Points: 
  • PRINCETON, N.J., March 11, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), today announced MicroMatrix® Flex is now available commercially in the U.S. MicroMatrix Flex is a dual-syringe system enabling the convenient mixing and precise delivery of MicroMatrix® paste to provide convenient access to hard-to-reach spaces and to help prepare an even wound surface in challenging wound areas.
  • “MicroMatrix Flex has allowed me to expand how I use UBM technology in complex wound reconstruction procedures,” said Dr. Aaron Moore, acute care surgeon, Mercy Health - St. Vincent Medical Center.
  • During this period, UBM has been published in more than 200 pre-clinical and clinical publications.
  • “We’re excited to be adding MicroMatrix Flex to our market-leading portfolio of dermal matrices,” commented Steve Powick, senior vice president, Global Marketing, Tissue Technologies Product Division.

Integra LifeSciences Announces Leadership Transition Plan

Retrieved on: 
Wednesday, February 28, 2024
Integra, Growth, Acceleration, Heidrick & Struggles, Trust, Workforce, Management

PRINCETON, N.J., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (“Integra” or “the Company”) (NASDAQ: IART), a leading global medical technology company, today announced that Jan De Witte has informed the Board of Directors (the “Board”) of his intention to retire from his position as president and chief executive officer of Integra following the appointment of a successor, which the Company expects to occur by the end of 2024. The Company also announced that Stuart Essig, Integra’s chairman, has been appointed to the role of executive chairman, effective immediately.

Key Points: 
  • “We are grateful to Jan for his leadership and commitment to Integra and the role he has played in advancing our portfolio and building upon our legacy of innovation,” said Stuart Essig, chairman of the Board.
  • “Jan’s personal decision to retire from Integra and return to Europe follows a leadership tenure marked by significant contributions to the company, including the evolution of our strategy and an expansion of core capabilities.
  • Mr. De Witte said, “I am incredibly proud of everything we have accomplished together here at Integra.
  • Mr. De Witte will address the leadership transition during Integra’s fourth quarter and full-year 2023 financial results conference call, which is scheduled for later today at 8:30 a.m.